APUS vs EOG
Apimeds Pharmaceuticals US, Inc. (APUS) versus EOG Resources Inc (EOG) — a side-by-side from cached financials, not a winner call.
Apimeds Pharmaceuticals US, Inc. (APUS) is a drug manufacturers - specialty & generic company listed on US.
EOG Resources Inc (EOG) is a oil & gas e&p company listed on US.
APUS does not have a complete income-statement cache yet.
Latest reported EOG revenue for 2025-12-31 was $22.63B. Net income was $4.98B. Revenue was down 4.5% from 2024-12-31 to 2025-12-31. EOG currently screens at market cap $66.44B and trailing P/E 11.3.
APUS currently screens at market cap $2.4M. EOG currently screens at market cap $66.44B and trailing P/E 11.3.
Not investment advice. Open the APUS and EOG stock pages for the full models.
Not investment advice.